We continue to run mobile clinics along the frontline, and increased psychological and medical support to people living in the areas controlled by the Ukrainian government, including those who had been displaced.
We also ensure continuity of care for people suffering from chronic diseases such as diabetes and hypertension, as the conflict has interrupted their access to drugs and medical services.
Our teams are currently responding to the coronavirus COVID-19 pandemic in Ukraine.
Curing hepatitis C in Ukraine with effective drugs and patient support
At least five per cent of the population - or two million people - in Ukraine are infected with hepatitis C, according to estimates from World Health Organization.
If left untreated, hepatitis C can lead to liver fibrosis, cirrhosis, liver cancer and even death. Fortunately, hepatitis C is preventable and curable.
Until recently, treatment for hepatitis C was painfully long and costly and came with toxic side effects. But newer direct-acting antivirals (DAAs) have revolutionised hepatitis C care, making treatment faster and more effective while significantly reducing side effects. Drug prices however remain prodigiously high and poor access to diagnosis severely limits scaling up the treatment.
In 2017, MSF opened a project in southern Ukraine that offers innovative hepatitis C treatment using advanced drugs that can cure hepatitis C in as little as 12 weeks.